Elequin Capital’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Elequin Capital’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-50,000	Closed	-$522K	–	677
2023 Q1	$522K	Hold	50,000	–	–	0.37%	29
2022 Q4	$510K	Buy	+50,000	New	+$506K	0.14%	108

Elequin Capital's LVAC Position: Q2 2023 in Review

Elequin Capital sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 50,000 shares — an estimated $522K sold.

Elequin Capital first reported a position in LVAC in Q4 2022 and held it in 2 quarters. The position peaked at $522K in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Elequin Capital reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Elequin Capital sold 50,000 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $522K.
Elequin Capital first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q4 2022 and held it in 2 quarters.
Elequin Capital's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $522K in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Elequin Capital's 13F filing for Q2 2023, filed 14 Aug 2023.